TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT05630352

A Study to Learn About Bivalent COVID-19 RNA Vaccine Candidate(s) in Healthy Infants and Children

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.
“Bivalent vaccine no longer epidemiologically relevant.”

The sponsor’s own words in the registry.

Life of this trial

20222023202420252026Registered2022-11-22Withdrawn (as of)2024-03-18Planned start2025-01-06 (planned)

Vital statistics

Status
Withdrawn
Phase
Phase 1
Sponsor
BioNTech SE
Sponsor type
Industry
Conditions
COVID-19
Interventions
Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose; Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 6 microgram dose; Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 10 microgram dose; Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 1 microgram dose
Participants
0

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.